Table 1 Characteristics of the liver transplant recipients that were biopsied
From: Liver biopsy is still needed in liver transplantation recipients: a single center experience
M ± SD | Range | |
|---|---|---|
Age years | 44.65 ± 8.46 | 25-58 |
Time till biopsy months | 19.88 ± 11.22 | 4-44 |
Follow-up months | 51.53 ± 15.92 | 10.0-93 |
Total bilirubin mg/dL | 1.96 ± 2.50 | 0.3-9.9 |
Serum albumin g/dL | 4.11 ± 0.62 | 2.7-5.1 |
AST U/L | 111.79 ± 67.08 | 30-270 |
ALT U/L | 125.59 ± 70.42 | 20-303 |
ALP U/L | 541.45 ± 1185.65 | 81-7120 |
GGT U/L | 486.3 ± 653.2 | 11-3408 |
Urea mg/dL | 41.97 ± 16.98 | 20-105 |
Serum creatinine mg/dL | 0.98 ± 0.29 | 0.5-1.7 |
Serum sodium mmol/L | 138.44 ± 4.04 | 129-146 |
Serum potassium mmol/L | 4.31 ± 0.46 | 3.8-5.7 |
Hemoglobin g/dL | 12.71 ± 2.09 | 7.7-17.6 |
WBCs 109/L | 6 ± 2.27 | 2.3-14.2 |
Platelets 109/L | 167.82 ± 83.32 | 59-398 |
INR | 1.05 ± 0.22 | 0.8-2.1 |
MELD | 8.74 ± 4.71 | 3-28 |
Liver Fibrosis | ||
None | 16 (47.1%) | |
F1 | 13 (38.2%) | |
F2 | 3 (8.8%) | |
F3 | 2 (5.9%) | |
Liver Activity | ||
None | 16 (47.1%) | |
A1 | 12 (35.3%) | |
A2 | 5 (14.7%) | |
A3 | 1 (2.9%) | |
Histopathology | ||
Acute rejection | 7 (20.6%) | |
Viral chronic hepatitis | 17 (50%) | |
Steatohepatitis | 4 (11.8%) | |
Biliary obstruction | 1 (2.9%) | |
CMV infection | 1 (2.9%) | |
Chronic rejection | 2 (5.9%) | |
Chronic hepatitis | 2 (5.9%) | |